SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses
Alexandra C. Walls, Kaitlin R. Sprouse, John E. Bowen, Anshu Joshi, Nicholas Franko, Mary Jane Navarro, Cameron Stewart, Elisabetta Cameroni, Matthew McCallum, Erin A. Goecker, Emily Degli-Angeli, Jenni Logue, Alexander L. Greninger, Davide Corti, Helen Y. Chu, David Veesler
Topics & Concepts
Neutralizing antibodyBiologyImmunologyAntibodyNeutralizationVirologyImmunityAntibody responseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PandemicCoronavirus disease 2019 (COVID-19)VaccinationAnthrax vaccinesAntibody-dependent enhancementImmune systemVirusImmunizationMedicineDiseaseInternal medicineInfectious disease (medical specialty)Viral replicationDNA vaccinationSARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesViral gastroenteritis research and epidemiology